South Texas Clinical Research

Menu
Facebook-f Instagram Linkedin-in

CLINICAL RESEARCH STUDY

SUNFLOWER Study

A Clinical Trial for Women with Non-Atypical Endometrial Hyperplasia (NAEH)

We are conducting a Phase 3 clinical research study evaluating whether the hormonal intrauterine system Mirena can effectively treat non-atypical endometrial hyperplasia — a thickening of the uterine lining without precancerous changes.

This study compares Mirena to oral Medroxyprogesterone acetate, a commonly used hormonal treatment.

Study overview

PURPOSE

To determine whether Mirena can return the uterine lining to normal after 6 months of treatment.

TOTAL PARTICIPATION TIME

Up to 10 months

STUDY DESIGN

  • Phase 3, randomized, open-label study
  • 2 treatment groups — Mirena or oral medroxyprogesterone acetate
  • 6 months of treatment + 3 months of follow-up
    Visits approximately every 3 months

Who may qualify

  • Age 18 or older
  • Abnormal bleeding or diagnosis of Non-Atypical Endometrial Hyperplasia
  • Willing to receive either an intrauterine system or oral hormone therapy
  • Meet additional study health criteria

Both premenopausal and postmenopausal women may qualify.

Why Participate

  • Close medical monitoring at no cost
  • Regular ultrasounds and biopsy evaluations
  • Contribution to research that may expand treatment options for women

COMPENSATION

Up to $1,600

For time and travel

Contact our study team